BackLifecore Biomedical Overview

Lifecore Biomedical Long Term Debt

Latest long-term debt for LFCR: $150M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$148.80M

Peer average

Loading

Lifecore Biomedical Long Term Debt History

Loading

Lifecore Biomedical vs. peers: Long Term Debt Comparison

Loading

Lifecore Biomedical Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lifecore Biomedical (LFCR) FAQ

As of the most recent data (March 2026), LFCR shows a long-term debt of $150M. Scroll down for historical charts and peer comparison views.

Tracking LFCR's long-term debt over time shows whether Lifecore Biomedical is scaling, shrinking, or reshaping that part of the business. The current reading is $150M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Lifecore Biomedical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $150M) with ownership activity and broader fundamentals.

Lifecore Biomedical's long-term debt is $150M; compare it with other Materials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.